Workflow
国际化
icon
Search documents
创维创始人黄宏生:去年光伏收入首超电视
Xin Lang Cai Jing· 2026-01-11 14:10
Core Insights - The founder of Skyworth Group, Huang Hongsheng, highlighted the importance of photovoltaic (PV) technology, AI home appliances, and internationalization during the 2026 annual speech [1] - Skyworth's PV revenue is projected to exceed its TV revenue for the first time in 2025 [1] - The growth of Skyworth's PV business is expected to be driven by overseas markets, with plans to enter the energy storage sector [1] Company Developments - Skyworth's PV business is anticipated to account for over one-third of the company's total revenue by mid-2025 [1] - The company began its foray into the PV sector in 2020, expanding from rural distributed PV systems to upstream core components, including modules, brackets, inverters, and a new energy digital ecosystem platform [1] - Skyworth has established a vertical industry chain in the photovoltaic sector [1]
第二届速度能力研究会议在暨南大学开幕
Xin Lang Cai Jing· 2026-01-11 01:43
本次会议为期两天,以"科技助力下的速度能力挖掘与训练"为主题,聚焦速度能力形成机制与训练优化 路径,旨在构建高水平、国际化、实战型的交流平台,推动基础研究与训练实践深度融合,为我国田径 及其他速度主导项目提供科技支撑。 中新网广州1月11日电 (记者 郭军)"中国速度·卓越竞技"第二届速度能力研究会议10日在暨南大学开幕。 来自国内外体育科学、运动训练等领域的专家学者、教练员、科研人员及师生代表约450人参会。 第二届速 度能力研究会议10日在暨南大学开幕。暨南大学 供图 度能力研究会议10日在暨南大学开幕。图为苏炳添在会上致辞。暨南大学 供图 暨南大学体育学院院长、苏炳添速度研究与训练中心主任苏炳添在致辞中回顾了自己从运动员转型为体 育科研与教育工作者的历程。他表示,中国速度项目的发展不能仅仅依靠个别运动员的突破,更需要有 系统化的科研平台、持续的人才培养以及跨学科的协同合作。他介绍了中心和实验室在速度训练、科研 融合以及青年人才培养方面所进行的探索,并呼吁与会学者加强交流与合作,共同推动中国速度训练体 系朝着科学化、国际化方向发展。 本届会议由暨南大学主办,苏炳添速度研究与训练中心、广东省速度能力研究重点 ...
汽车“自主五强”的2025年:增长之下现战略分野
经济观察报· 2026-01-10 08:22
Core Viewpoint - The Chinese automotive market is entering a critical phase in 2025, with domestic brands collectively capturing nearly 70% of the passenger car market share, driven by the rise of new energy vehicles and international expansion [2][4]. Group 1: Market Dynamics - The "self-owned five strong" brands, including BYD, Geely, Chery, Changan, and Great Wall, have established a stable market presence, with total sales of 14.67 million units, accounting for over half of the overall passenger car market [2][4]. - BYD leads the global new energy vehicle sales with 4.6024 million units sold in 2025, marking a 7.73% year-on-year increase, while its pure electric vehicle sales reached approximately 2.257 million units, surpassing Tesla [4][5]. - Geely's total sales exceeded 3.02 million units in 2025, a 39% increase, with new energy vehicle sales reaching 1.6878 million units, reflecting a 90% growth [5][6]. Group 2: Strategic Developments - Geely has initiated a significant restructuring by merging with Zeekr Technology to enhance operational efficiency and resource integration, aiming to save billions in R&D costs annually [9][10]. - Chery has restructured its brand architecture to improve domestic market efficiency, establishing a new business group to streamline operations and enhance competitiveness [9][10]. - Changan has launched a 6 billion yuan capital increase plan to support the development of new energy vehicles and global R&D centers, reinforcing its strategic alignment with major shareholders [10][11]. Group 3: Technological Advancements - The competition among Chinese automakers has evolved from individual technological breakthroughs to a more systemic confrontation, with companies like BYD and Geely focusing on comprehensive technology integration and smart driving solutions [11][12]. - Great Wall has introduced a next-generation intelligent super platform that supports various powertrains, emphasizing its advancements in smart cockpit and driving technologies [12].
万孚生物坚定“AI创新+国际化”双战略 引领2026发展新升级
Zheng Quan Ri Bao Wang· 2026-01-09 13:45
Core Viewpoint - Guangzhou Wanfeng Biotechnology Co., Ltd. (Wanfeng Bio) anticipates a net profit attributable to shareholders of 46 million to 69 million yuan for the year 2025, amid significant adjustments in the IVD (in vitro diagnostics) sector, leading to a temporary decline in business performance [1] Domestic Market - The revenue from the colloidal gold and fluorescence product lines in the grassroots medical market has decreased, resulting in reduced profitability [1] - The launch of the FG-3000 gold standard reading instrument enhances operational efficiency in higher-tier hospitals, laying a solid hardware foundation for the digitalization and intelligence of gold standard business [1] - The introduction of new products such as the norovirus detection in the digestive tract business and the stabilization of terminal sales in the fluorescence business are noted, with significant growth in the grassroots public health glycosylated hemoglobin screening business [1] - The LA-1000 fluorescence level linking system has significantly improved automation and intelligence in emergency and outpatient services, while the LA-6000 intelligent laboratory assembly line has been successfully launched, with new projects like the six-item thrombosis test rapidly scaling up, resulting in a 40% year-on-year increase in terminal sales [1] Overseas Market - The overseas business continues to grow, with overseas revenue surpassing domestic revenue for the first time, providing crucial support for the company's sustainable growth [2] - The localization process in key countries has deepened, with an increasing share in small and medium laboratories in international markets [2] - In the North American market, the introduction of respiratory business has led to significant growth, with a long-term supply agreement signed with a major U.S. client for respiratory triad testing products, establishing a solid foundation for strategic layout in the U.S. respiratory infectious disease market [2] - By the end of 2025, the company will enter a new product harvest period, having obtained registration for several important single products, including a triad testing kit for respiratory syncytial virus, mycoplasma pneumonia, and adenovirus [2] Investment and Ecosystem Development - The company's direct investment in digital and AI pathology projects has seen rapid growth under the guidance of new national healthcare policies [3] - The "Intelligent Auxiliary Analysis Software for Coagulation Disorders" developed by the company has been selected for the "2025 Artificial Intelligence Medical Device Innovation Task" list, marking a substantial breakthrough in the strategic layout of AI-assisted diagnosis and laying a solid foundation for future clinical needs and commercialization [3] - In 2026, the company aims to leverage recovery in the domestic market, focusing on grassroots stability, and achieve rapid revenue improvement through the luminescence and molecular product lines [3] - The company will continue to expand its brand and channel advantages in overseas and North American markets to achieve high growth, while leveraging favorable policies to commercialize existing AI breakthroughs in pathology and clinical diagnosis [3]
海思科与AirNexis签署HSK39004项目授权许可协议
Bei Jing Shang Bao· 2026-01-09 13:08
北京商报讯(记者 丁宁)1月9日晚间,海思科(002653)发布公告称,公司与美国AirNexis Therapeutics, Inc.(曾用名DragonwellBiosciences, Inc.,以下简称"AirNexis")签订独占许可协议,授予 AirNexis在除中国大陆、香港特别行政区、澳门特别行政区及台湾地区以外的全球范围内开发、生产和 商业化HSK39004的独家权利。AirNexis将向海思科支付1.08亿美元首付款(含4000万美元现金及等值约 6800万美元的AirNexis公司19.9%股权)及最高9.55亿美元的额外里程碑付款、特许权使用费。AirNexis 如果就HSK39004达成再许可交易,海思科还有权获得再许可收入分成。 海思科表示,本次协议的签署,将进一步推动HSK39004在全球范围内的开发与商业化进程。此举与公 司坚持国际化、创新驱动的整体发展战略高度契合,是公司深化全球布局、加速创新成果转化的重要一 步。该协议的签订预计将对公司未来业绩产生积极影响,有利于提升公司的盈利能力。 ...
报告:中国汽车行业淘汰赛已进入深化阶段
Zhong Guo Xin Wen Wang· 2026-01-09 12:05
Core Insights - The report by Roland Berger highlights significant transformations in the Chinese automotive industry, projecting a total vehicle sales of approximately 34 million units in 2025, with around 7 million units expected to be exported, showcasing a strong shift towards new energy vehicles with penetration rates exceeding 50% monthly from mid-year and surpassing 60% in December [3][4] Group 1: Industry Trends - The Chinese automotive market is anticipated to undergo a balance restructuring phase in the next three to five years, driven by ecological innovation and global market dynamics [3] - Six key transformative themes for 2026 have been identified: elimination competition, deepening transformation battles, further internationalization, technology competition, capital competition, and AI competition [4] Group 2: Market Dynamics - The competitive landscape will increasingly favor leading companies, with a market structure evolving into a few top-tier firms, several mid-tier firms, and a large number of lower-tier companies [4] - The automotive sector is transitioning from traditional transportation to smart devices, necessitating cross-industry collaborations with sectors such as chips, software, energy, and cloud computing [5] Group 3: Technological and Capital Considerations - The core product capabilities of vehicles will shift from traditional transport functions to AI-driven intelligent forms, including advancements in autonomous driving and new materials [5] - In a context of pressured overall profit margins, the ability to leverage capital effectively and enhance core operational efficiency will be crucial for distinguishing the positioning of various companies [5]
恒瑞医药:2025年上半年公司创新药销售及许可收入95.61亿元
(编辑 丛可心) 证券日报网讯 1月9日,恒瑞医药在互动平台回答投资者提问时表示,公司坚持科技创新与国际化两大 发展战略,创新成果转化高效赋能,创新药销售引领业绩增长。2025年上半年,公司创新药销售及许可 收入95.61亿元,占公司营业收入比重60.66%。此外,公司自2023年以来达成12笔创新成果对外授权, 潜在总交易额超270亿美元。公司将继续大力推进"科技创新"和"国际化"两大发展战略,稳步推进研发 创新和制剂产品的国际化。同时,也将着力于产品结构的优化提升,通过产品创新升级和多元化产品管 线的拓展推动公司的持续发展,促进公司业绩可持续增长,以更好的发展回馈股东。 ...
恒瑞医药:二级市场股价受多重因素影响
Zheng Quan Ri Bao Wang· 2026-01-09 11:40
证券日报网讯1月9日,恒瑞医药(600276)在互动平台回答投资者提问时表示,二级市场股价受宏观经 济、市场情绪等多重因素影响。公司将继续大力推进"科技创新"和"国际化"两大发展战略,稳步推进研 发创新和制剂产品的国际化。同时,也将着力于产品结构的优化提升,通过产品创新升级和多元化产品 管线的拓展推动公司的持续发展,促进公司业绩可持续增长,以更好地发展回馈股东。 ...
无锡老板卖两轮车,暴赚29亿多
Core Viewpoint - Yadea Holdings is experiencing a significant rebound in business, with projected net profit for 2025 expected to reach at least 2.9 billion yuan, a substantial increase from 1.27 billion yuan in the previous year, driven by increased electric two-wheeler sales and optimized product structure [2][3]. Group 1: Financial Performance - In the first half of 2025, Yadea sold a total of 8.7935 million electric scooters and bicycles, an increase of approximately 2.4 million units compared to the same period last year, resulting in a main business revenue of 19.186 billion yuan, a surge of about 33.1% [4]. - The company faced a profit decline in 2024 due to decreased sales and lower inventory prices, but has since turned around to achieve a new profit peak [3]. Group 2: Strategic Initiatives - Yadea has adopted a youth-oriented strategy, launching the "Modern Series" specifically for female riders, emphasizing retro and luxury aesthetics, and introducing the "Crown T35" model inspired by robotics to attract young riders seeking stylish design and performance [5]. - The company has also engaged Wang Hedi as a brand ambassador since the end of 2024, which has significantly contributed to enhancing brand awareness and engagement [5]. Group 3: Regulatory and Market Environment - The favorable policy environment, including trade-in programs, new national standards, and the "white list" policy, has benefited leading two-wheeler companies [4]. - Yadea has issued an apology for design oversights in its "Maodou" series, addressing issues such as child safety and storage space, and has launched 68 models compliant with new national standards to cater to various daily commuting scenarios [6]. Group 4: Expansion and Innovation - Yadea is strengthening its focus on smart technology and international expansion, having established a presence in 100 countries and set up ten major smart production and research bases in regions including China, Vietnam, Indonesia, and Thailand [9]. - The company showcased its new electric motorcycle flagship at the Milan International Two-Wheeler Exhibition, featuring a long-range version with a range of 170 kilometers, specifically targeting European users [10]. - Yadea has introduced a comprehensive energy replenishment ecosystem covering various scenarios, including 24-hour self-service battery swap stations and solar energy systems, along with a rapid charging solution [10].
广汽集团销量连续3个季度环比增长
Zheng Quan Shi Bao· 2026-01-07 18:09
Core Viewpoint - GAC Group has shown significant growth in vehicle sales and is actively innovating and reforming its operations to adapt to the changing automotive industry [1][2]. Group 1: Sales Performance - In December 2025, GAC Group's vehicle sales exceeded 187,400 units, representing a month-on-month increase of 4.3% [1]. - The total vehicle sales for the year 2025 reached 1.7215 million units, with terminal sales at 1.8135 million units [1]. - In Q4 2025, GAC Group's sales surpassed 537,800 units, marking a 25.56% increase compared to Q3 [1]. Group 2: Product Innovation and Development - GAC Aion's sales in December 2025 reached 42,000 units, with a month-on-month growth of 10% [1]. - GAC Trumpchi's annual sales of new energy vehicles exceeded 150,000 units [1]. - GAC Toyota achieved annual sales of 756,000 units, reflecting a year-on-year growth of 2.4% [1]. - GAC Honda's December sales exceeded 50,000 units, with a month-on-month increase of 23.3% [1]. Group 3: Organizational Reforms - GAC Group is advancing the "Panyu Action" integrated reform, focusing on breaking down organizational barriers and enhancing talent management [1]. - The company has deepened its IPD (Integrated Product Development) and DSTE (From Strategy to Execution) system reforms, reducing new model development cycles to 18-21 months and cutting R&D costs by over 10% [1]. Group 4: Supply Chain and Technology - GAC Group has established a complete automotive chip matrix and launched 12 high-safety automotive-grade chips in collaboration with domestic chip companies [2]. - The company is accelerating its layout in advanced technologies, with a pilot production line for solid-state batteries completed in November 2025, aiming for small batch vehicle trials in 2026 [2]. Group 5: International Expansion - In 2025, GAC Group introduced five new models to overseas markets, with nearly 130,000 units sold abroad, representing a year-on-year growth of 47% [2].